Open AccessFractionated radioimmunotherapy with 90Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial
Author(s) -
Allyson J. Ocean,
Kenneth Pennington,
Michael J. Guarino,
Arif Sheikh,
Tanios BekaiiSaab,
Aldo N. Serafini,
Daniel Lee,
Max W. Sung,
Seza A. Güleç,
Stanley J. Goldsmith,
Timothy Manzone,
Michael Holt,
Bert H. O’Neil,
Nathan C. Hall,
Alberto J. Montero,
John S. Kauh,
David V. Gold,
Heather Horne,
William A. Wegener,
David M. Goldenberg
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/28jb-2m68
Subject(s) - radioimmunotherapy , gemcitabine , oncology , medicine , pancreatic cancer , cancer , nuclear medicine , immunology , monoclonal antibody , antibody